← Browse by Condition
Medical Condition

fetal alcohol spectrum disorders

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for fetal alcohol spectrum disorders sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — fetal alcohol spectrum disorders Clinical Trials

How many clinical trials are currently recruiting for fetal alcohol spectrum disorders?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for fetal alcohol spectrum disorders, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for fetal alcohol spectrum disorders?
fetal alcohol spectrum disorders research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a fetal alcohol spectrum disorders clinical trial?
Eligibility criteria for fetal alcohol spectrum disorders trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Wayne State University 1 trial
University of Oklahoma 1 trial
University of California, Los Angeles 1 trial

Recruiting Clinical Trials

NCT04395196 Phase 2
Recruiting
RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
Enrollment
288 pts
Location
South Africa
Sponsor
Wayne State University
View Trial →
NCT05534568
Recruiting
The Oklahoma Parent-Child Assistance Program
Enrollment
200 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT06847165
Recruiting
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Enrollment
30 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →

Related Conditions

fetal alcohol syndrome (2) substance use disorders (1) pregnancy related (1) alcohol use disorder aud (1) alcohol use complicating pregnancy first trimester (1) alcohol use complicating pregnancy second trimester (1) alcohol use complicating pregnancy third trimester (1) alcohol use complicating pregnancy unspecified trimester (1) alcohol use complicating pregnancy childbirth and the puerperium (1) drug use disorders (1) drug use complicating pregnancy first trimester (1) drug use complicating pregnancy second trimester (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology